Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06136871 · ClinicalTrials.gov registry record · NA
Cognitive Rehabilitation in Post-COVID-19 Syndrome
A NA study of Post COVID-19 Syndrome, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT06136871 is a NA study of Post COVID-19 Syndrome that has completed, run by University of Missouri-Columbia. The registered enrollment target is 65 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06136871, a NA study of Post COVID-19 Syndrome, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
The first aim of this study is to determine the feasibility of delivering CO-OP remotely to individuals experiencing cognitive impairments that limit everyday activities in post-COVID-19 syndrome (PCS). The second aim of this study is to assess the effect of CO-OP on activity performance, subjective and objective cognition, and quality of life in a sample of individuals with PCS. The research team hypothesizes that effect size estimations will indicate that CO-OP will have a greater positive effect, compared to an inactive control group, on activity performance, subjective and objective cognition, and quality of life in a sample of individuals who self-report PCS and cognitive impairment.
Conditions Studied
Interventions
- BEHAVIORAL Inactive Control Group
- BEHAVIORAL CO-OP Procedures
Study Locations (1)
Missouri
- University of Missouri Department of Occupational Therapy - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06136871
The ClinicalTrials.gov registry entry for NCT06136871 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post COVID-19 Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Inactive Control Group is the first listed.
NCT06136871 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT06136871 about?
NCT06136871 is a clinical study titled "Cognitive Rehabilitation in Post-COVID-19 Syndrome". The first aim of this study is to determine the feasibility of delivering CO-OP remotely to individuals experiencing cognitive impairments that limit everyday activities in post-COVID-19 syndrome (PCS). The second aim of this study is to assess the effect of CO-OP on activity performance, subjective...
What is the current status of trial NCT06136871?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2024-02-01. Estimated completion is 2025-06-30.
What conditions does trial NCT06136871 study?
This clinical trial studies the following conditions: Post COVID-19 Syndrome.
What interventions are being tested in trial NCT06136871?
The interventions under investigation include: Inactive Control Group (BEHAVIORAL), CO-OP Procedures (BEHAVIORAL).
Who is sponsoring clinical trial NCT06136871?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06136871 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post COVID-19 Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.